Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06512350 · ClinicalTrials.gov registry record

Identifying Patterns in the Breath of Individuals With Breast Cancer

A clinical trial of Breast Cancer, sponsored by Breathe BioMedical.

Recruiting
Registry status
1,000
Enrollment target
3
Study locations

NCT06512350: Recruiting study of Breast Cancer, sponsored by Breathe BioMedical.

NCT06512350 is a study of Breast Cancer that is actively recruiting participants, run by Breathe BioMedical. The registered enrollment target is 1,000 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06512350, a study of Breast Cancer, is actively recruiting participants, sponsored by Breathe BioMedical.

RECRUITING
Registry status
1,000 participants
Enrollment target
3
Study locations

Study Summary

Researchers will compare the breath profiles of women with breast cancer and those without to determine whether there are disease-specific patterns that can be leveraged to facilitate breast cancer detection. Women with mammogram-confirmed dense breast tissues undergoing standard-of-care breast cancer screening will be invited to participate. Those who provide informed consent will provide one breath sample and fill out a questionnaire about their medical history with help from the research coordinators. Breath samples will be collected prior to standard of care biopsy or MRI, and patients will be stratified into the case or control group based on their test results. The primary goal of this project is to use exhaled alveolar breath and the subsequent spectral data produced by Breathe BioMedical's cavity ring-down spectrometer to further develop Breathe BioMedical's technology and machine learning algorithms to determine the feasibility of detecting breast cancer in women with dense breast tissue. Secondarily, this project aims to identify patterns of VOCs that are either over- or under-represented in participants with breast cancer when compared to the breath profiles of participants without breast cancer. This project will also assess performance characteristics of the technology (e.g. sensitivity, specificity, false negative rate, and false positive rate) including subgroup analyses. This project aims to understand intra-subject variability by exploring differences in breath signatures before and after definitive management of breast cancer, including surgical resection.

Primary Outcome

Classification performance metrics characteristics (e.g. sensitivity, specificity, false negative rate, and false positive rate) derived from spectral features of exhaled alveolar breath obtained using Breathe BioMedical's cavity ring-down spectrometer in women aged 40-74.

Conditions Studied

Study Locations (3)

District of Columbia

  • GW Comprehensive Breast Center - Washington D.C.

Florida

  • Mayo Clinic Breast Clinic - Jacksonville

North Carolina

  • Duke University Medical Cente - Durham

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-02-25
Est. Completion 2026-12
Breathe BioMedical

3 total trials

What NCT06512350 shows while recruiting

NCT06512350 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT06512350 reports a single indexed study location in District of Columbia, Florida, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06512350 about?

NCT06512350 is a clinical study titled "Identifying Patterns in the Breath of Individuals With Breast Cancer". Researchers will compare the breath profiles of women with breast cancer and those without to determine whether there are disease-specific patterns that can be leveraged to facilitate breast cancer detection. Women with mammogram-confirmed dense breast tissues undergoing standard-of-care breast can...

What is the current status of trial NCT06512350?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-02-25. Estimated completion is 2026-12.

What conditions does trial NCT06512350 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT06512350?

This trial is sponsored by Breathe BioMedical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06512350 being conducted?

This trial has 3 study locations across District of Columbia, Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06512350's enrollment target sits among peer trials

1,000 120th of 1224 higher than 1,097 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06512350, the US trial registry maintained by the National Library of Medicine. NCT06512350 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.